News
A University of Pennsylvania biotechnology company that aims to treat autoimmune diseases by reengineering cells within the ...
A novel chimeric antigen receptor T-cell therapy may benefit patients with B-cell lymphomas who previously relapsed following ...
1d
The Times of Israel on MSNZelig Eshhar, leading cancer researcher and immunologist, dies at 84Research by Weizmann Institute scientist and Israel Prize winner saved 'countless lives,' was basis for technology sold for ...
A team of physicians recently reported the successful treatment of refractory autoimmune neuropathies through the infusion of ...
While data is promising, many questions remain about topics such as timing and doses in the treatment of hematologic malignancies.
3d
News Medical on MSNStudy unveils powerful strategy to rejuvenate effectiveness of CAR T cell therapy against glioblastomaA team of researchers from the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET, Milan), led by Nadia Coltella and ...
Chimeric antigen receptor (CAR) therapies utilize engineered receptors that are able to redirect immune cells to identify and destroy cancer cells that express a specific antigen. At present, CAR ...
During a live event, Priyanka Pophali, MD, MBBS, discussed CAR T-cell therapy referrals, timing, and challenges in relapsed ...
chimeric antigen receptor 1 Articles . CRISPR Could Fry All Cancer Using Newly Found T-Cell. January 27, 2020 by Kristina Panos 36 Comments . One of the human body’s greatest features is its ...
4d
Interesting Engineering on MSNCredit-card-sized chip reveals how immune cells hunt and kill cancer in real timeEngineered chip mimics bone marrow and immune system, offering a faster, tailored path for cancer immunotherapy.
To the Editor: Garfall et al. (Sept. 10 issue)1 describe an interesting case of a patient with multiple myeloma who was successfully treated with autologous stem-cell transplantation followed by in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results